Daiichi Sankyo, a global pharmaceutical company, is seeking opportunities to collaborate with institutes seeking protease inhibitors for disease treatment. Daiichi Sankyo has in‑house technology to make specific protease inhibitors and would ideally like to work with researchers who have identified proteases involved in mediating diseases, but who have not yet developed an inhibitor for the target protease.
Approaches of Interest:
- All disease areas that do not currently have protease inhibitor treatment are of interest
- There is a particular interest in...